InvestorsHub Logo
Followers 1
Posts 171
Boards Moderated 0
Alias Born 06/06/2018

Re: None

Friday, 10/19/2018 8:06:41 AM

Friday, October 19, 2018 8:06:41 AM

Post# of 44784
WIDETRIAL SEEKS TO INCREASE EXPANDED ACCESS PROGRAMS BY HELPING COMPANIES RECOVER COSTS:


https://www.biocentury.com/bc-extra/company-news/2018-10-18/widetrial-seeks-increase-expanded-access-programs-helping-


“Traditionally, clinical stage drug companies haven’t been well rewarded for serving the treatment needs of patients outside of research trials," WideTrial founder and CEO Jess Rabourn told BioCentury. "In fact, there are more perceived downsides than upsides."

"Rabourn estimates that fewer than 10 companies have engaged in cost recovery for a group EAP in the U.S."